Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia

DA Sandoval, ME Patti - Nature Reviews Endocrinology, 2023‏ - nature.com
Although promising therapeutics are in the pipeline, bariatric surgery (also known as
metabolic surgery) remains our most effective strategy for the treatment of obesity and type 2 …

Effect of bariatric surgery on metabolic diseases and underlying mechanisms

Y Ji, H Lee, S Kaura, J Yip, H Sun, L Guan, W Han… - Biomolecules, 2021‏ - mdpi.com
Obesity is a highly prevalent public health concern, attributed to multifactorial causes and
limited in treatment options. Several comorbidities are closely associated with obesity such …

[HTML][HTML] European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, R Barazzoni, L Busetto… - Clinical Nutrition, 2022‏ - Elsevier
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Combined GLP-1, oxyntomodulin, and peptide YY improves body weight and glycemia in obesity and prediabetes/type 2 diabetes: a randomized, single-blinded …

P Behary, G Tharakan, K Alexiadou, N Johnson… - Diabetes …, 2019‏ - diabetesjournals.org
OBJECTIVE Roux-en-Y gastric bypass (RYGB) augments postprandial secretion of
glucagon-like peptide 1 (GLP-1), oxyntomodulin (OXM), and peptide YY (PYY) …

[HTML][HTML] Do gut hormones contribute to weight loss and glycaemic outcomes after bariatric surgery?

D Papamargaritis, CW le Roux - Nutrients, 2021‏ - mdpi.com
Bariatric surgery is an effective intervention for management of obesity through treating
dysregulated appetite and achieving long-term weight loss maintenance. Moreover …

Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia

J Hazlehurst, B Khoo, CB Lobato… - Endocrine …, 2024‏ - ec.bioscientifica.com
Post-bariatric hypoglycaemia (PBH) is typically a post-prandial hypoglycaemia occurring
about 2–4 h after eating in individuals who have undergone bariatric surgery. PBH develops …

The effects of bariatric surgery on islet function, insulin secretion, and glucose control

JD Douros, J Tong, DA D'Alessio - Endocrine reviews, 2019‏ - academic.oup.com
Although bariatric surgery was developed primarily to treat morbid obesity, evidence from
the earliest clinical observations to the most recent clinical trials consistently demonstrates …

Mediators of amylin action in metabolic control

CN Boyle, Y Zheng, TA Lutz - Journal of clinical medicine, 2022‏ - mdpi.com
Amylin (also called islet amyloid polypeptide (IAPP)) is a pancreatic beta-cell hormone that
is co-secreted with insulin in response to nutrient stimuli. The last 35 years of intensive …

European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint European Society for Clinical Nutrition and Metabolism/United European …

SC Bischoff, R Barazzoni, L Busetto… - United European …, 2022‏ - Wiley Online Library
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass–a systematic review

RJ Jalleh, MM Umapathysivam, MP Plummer… - Reviews in Endocrine …, 2023‏ - Springer
Background and aims: Bariatric surgery is the most effective treatment in individuals with
obesity to achieve remission of type 2 diabetes. Post-bariatric surgery hypoglycaemia occurs …